CD8+ T cell Adaptive Vaccine (Emergex Vaccines)

N/A

Report date: 2025/06/11 10:57:55

Base Information

Drug NameCD8+ T cell Adaptive Vaccine (Emergex Vaccines)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSmallpoxMonkeypox
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsSmallpoxMonkeypox
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A